306 related articles for article (PubMed ID: 14759803)
1. BDNF gene-modified mesenchymal stem cells promote functional recovery and reduce infarct size in the rat middle cerebral artery occlusion model.
Kurozumi K; Nakamura K; Tamiya T; Kawano Y; Kobune M; Hirai S; Uchida H; Sasaki K; Ito Y; Kato K; Honmou O; Houkin K; Date I; Hamada H
Mol Ther; 2004 Feb; 9(2):189-97. PubMed ID: 14759803
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic efficacy of lentiviral vector mediated BDNF gene-modified MSCs in cerebral infarction].
Huang D; Zhang Z; Chen B; Wu X; Wang N; Zhang Y
Sheng Wu Gong Cheng Xue Bao; 2008 Jul; 24(7):1174-9. PubMed ID: 18837391
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal stem cells that produce neurotrophic factors reduce ischemic damage in the rat middle cerebral artery occlusion model.
Kurozumi K; Nakamura K; Tamiya T; Kawano Y; Ishii K; Kobune M; Hirai S; Uchida H; Sasaki K; Ito Y; Kato K; Honmou O; Houkin K; Date I; Hamada H
Mol Ther; 2005 Jan; 11(1):96-104. PubMed ID: 15585410
[TBL] [Abstract][Full Text] [Related]
4. Comparsion between Intravenous Delivered Human Fetal Bone Marrow Mesenchymal Stromal Cells and Mononuclear Cells in the Treatment of Rat Cerebral Infarct.
Huang AH; Zhang PP; Zhang B; Ma BQ; Guan YQ; Zhou YD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):497-506. PubMed ID: 27825404
[TBL] [Abstract][Full Text] [Related]
5. Adenovirus-mediated brain-derived neurotrophic factor expression regulated by hypoxia response element protects brain from injury of transient middle cerebral artery occlusion in mice.
Shi Q; Zhang P; Zhang J; Chen X; Lu H; Tian Y; Parker TL; Liu Y
Neurosci Lett; 2009 Nov; 465(3):220-5. PubMed ID: 19703519
[TBL] [Abstract][Full Text] [Related]
6. Intravenous administration of glial cell line-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in the adult rat.
Horita Y; Honmou O; Harada K; Houkin K; Hamada H; Kocsis JD
J Neurosci Res; 2006 Nov; 84(7):1495-504. PubMed ID: 16998918
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cell transplantation attenuates brain injury after neonatal stroke.
van Velthoven CT; Sheldon RA; Kavelaars A; Derugin N; Vexler ZS; Willemen HL; Maas M; Heijnen CJ; Ferriero DM
Stroke; 2013 May; 44(5):1426-32. PubMed ID: 23539530
[TBL] [Abstract][Full Text] [Related]
8. I.V. infusion of brain-derived neurotrophic factor gene-modified human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult rat.
Nomura T; Honmou O; Harada K; Houkin K; Hamada H; Kocsis JD
Neuroscience; 2005; 136(1):161-9. PubMed ID: 16229956
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus vector-mediated ex vivo gene transfer of brain-derived neurotrophic factor (BDNF) tohuman umbilical cord blood-derived mesenchymal stem cells (UCB-MSCs) promotescrush-injured rat sciatic nerve regeneration.
Hei WH; Almansoori AA; Sung MA; Ju KW; Seo N; Lee SH; Kim BJ; Kim SM; Jahng JW; He H; Lee JH
Neurosci Lett; 2017 Mar; 643():111-120. PubMed ID: 28215880
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective Effects of Brain-Derived Neurotrophic Factor and Noggin-Modified Bone Mesenchymal Stem Cells in Focal Cerebral Ischemia in Rats.
Lu H; Liu X; Zhang N; Zhu X; Liang H; Sun L; Cheng Y
J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):410-8. PubMed ID: 26654668
[TBL] [Abstract][Full Text] [Related]
11. Elevated brain derived neurotrophic factor levels in plasma reflect in vivo functional viability of infused mesenchymal stem cells for stroke in rats.
Nakamura H; Sasaki Y; Sasaki M; Kataoka-Sasaki Y; Oka S; Nakazaki M; Namioka T; Namioka A; Onodera R; Suzuki J; Nagahama H; Mikami T; Wanibuchi M; Kocsis JD; Honmou O
J Neurosurg Sci; 2019 Feb; 63(1):42-49. PubMed ID: 28181779
[TBL] [Abstract][Full Text] [Related]
12. Improvement of deficits by transplantation of lentiviral vector-modified human amniotic mesenchymal cells after cerebral ischemia in rats.
Tao J; Ji F; Liu B; Wang F; Dong F; Zhu Y
Brain Res; 2012 Apr; 1448():1-10. PubMed ID: 22386515
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection by PlGF gene-modified human mesenchymal stem cells after cerebral ischaemia.
Liu H; Honmou O; Harada K; Nakamura K; Houkin K; Hamada H; Kocsis JD
Brain; 2006 Oct; 129(Pt 10):2734-45. PubMed ID: 16901914
[TBL] [Abstract][Full Text] [Related]
14. Intravenously Delivered Allogeneic Mesenchymal Stem Cells Bidirectionally Regulate Inflammation and Induce Neurotrophic Effects in Distal Middle Cerebral Artery Occlusion Rats Within the First 7 Days After Stroke.
Li X; Huang M; Zhao R; Zhao C; Liu Y; Zou H; Chen L; Guan Y; Zhang YA
Cell Physiol Biochem; 2018; 46(5):1951-1970. PubMed ID: 29719282
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of human mesenchymal stem cells promotes functional improvement and increased expression of neurotrophic factors in a rat focal cerebral ischemia model.
Wakabayashi K; Nagai A; Sheikh AM; Shiota Y; Narantuya D; Watanabe T; Masuda J; Kobayashi S; Kim SU; Yamaguchi S
J Neurosci Res; 2010 Apr; 88(5):1017-25. PubMed ID: 19885863
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effect of BDNF-overexpressing human neural stem cells (HB1.F3.BDNF) in a rodent model of middle cerebral artery occlusion.
Chang DJ; Lee N; Choi C; Jeon I; Oh SH; Shin DA; Hwang TS; Lee HJ; Kim SU; Moon H; Hong KS; Kang KS; Song J
Cell Transplant; 2013; 22(8):1441-52. PubMed ID: 23044072
[TBL] [Abstract][Full Text] [Related]
17. Human umbilical cord blood-derived mesenchymal stem cells improve functional recovery through thrombospondin1, pantraxin3, and vascular endothelial growth factor in the ischemic rat brain.
Park HW; Moon HE; Kim HS; Paek SL; Kim Y; Chang JW; Yang YS; Kim K; Oh W; Hwang JH; Kim JW; Kim DG; Paek SH
J Neurosci Res; 2015 Dec; 93(12):1814-25. PubMed ID: 26332684
[TBL] [Abstract][Full Text] [Related]
18. Synergistic therapeutic effects of intracerebral transplantation of human modified bone marrow-derived stromal cells (SB623) and voluntary exercise with running wheel in a rat model of ischemic stroke.
Yabuno S; Yasuhara T; Nagase T; Kawauchi S; Sugahara C; Okazaki Y; Hosomoto K; Sasada S; Sasaki T; Tajiri N; Borlongan CV; Date I
Stem Cell Res Ther; 2023 Jan; 14(1):10. PubMed ID: 36691091
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic benefits of angiogenetic gene-modified human mesenchymal stem cells after cerebral ischemia.
Toyama K; Honmou O; Harada K; Suzuki J; Houkin K; Hamada H; Kocsis JD
Exp Neurol; 2009 Mar; 216(1):47-55. PubMed ID: 19094989
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effect of human placenta-derived cell treatment of stroke in rats.
Chen J; Shehadah A; Pal A; Zacharek A; Cui X; Cui Y; Roberts C; Lu M; Zeitlin A; Hariri R; Chopp M
Cell Transplant; 2013; 22(5):871-9. PubMed ID: 22469567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
